NewcelX Ltd. NCEL
2.78 USD +0.06 (+2.04%)
At closeNov 10, 2026, 4:01 AM EST
2.79 +0.01 +0.36%
Pre-market · Nov 10, 4:01 AM ET
2.60 Day range 2.88
1.83 52-week range 5.12
- YTD
- +46.32%
- 1 year
- -28.53%
- Market cap
- 16.06M
- EPS (ttm)
- 0.52
- P/E ratio
- 5.35
- YTD return
- +46.32%
- 1-year return
- -28.53%
- Volume
- 21.35K
- Avg volume
- 13.41K
- Open
- 2.78
- Previous close
- 2.72
- Day's range
- 2.60 – 2.88
- 52-week range
- 1.83 – 5.12
5D +0.38 (+15.83%)
Financials — quick view
NCEL Revenue — annual 0
NCEL Net income — annual -8.30M
NCEL EPS — annual -2.16
News
CORRECTION: NewcelX Announces $1.55M Private Placement Of 471,125 Common Shares And One Series Of Warrants At A Price Of $3.29 Per Share 
12 Health Care Stocks Moving In Friday's Pre-Market Session 
NewcelX Enters into Binding Term Sheet to Divest Legacy Mazindol Portfolio (CVR), Providing for Upfront Cash, Equity Ownership and Up to $55 Million in Potential Milestone Payments 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
12 Health Care Stocks Moving In Thursday's Pre-Market Session - 12 Health Care Stocks Moving In Friday's Pre-Market Session
NewcelX Issued Patent From Brazilian Patent And Trademark Office For Its Nnovative Cell Selection And Enrichment Technology 
Laidlaw & Co. Initiates Coverage On NewcelX with Buy Rating, Announces Price Target of $23 
NewcelX Completes Type B Pre-IND Meeting With FDA; Administration Provided Constructive Feedback And Alignment On Proposed Strategy - NewcelX Announces Publication Of Peer-Reviewed Study On The Potential Of AstroRx, A Human Embryonic Stem Cells-Derived Astrocyte Therapy, In The Journal Stem Cell Reports
Your note
Sign in to keep a note on NCEL — it syncs with the Stock Master app.